Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor
Clinical trial NCT02261207 · COMPLETED
Trial details
- NCT number
- NCT02261207
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2017-10-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.